Literature DB >> 1540038

Differences in HLA antigens between patients with mixed connective tissue disease and systemic lupus erythematosus.

P Ruuska1, R Hämeenkorpi, S Forsberg, H Julkunen, R Mäkitalo, J Ilonen, A Tiilikainen.   

Abstract

Patients with mixed connective tissue disease (MCTD, n = 32) or systemic lupus erythematosus (SLE, n = 60) were typed for HLA-A, B, C, Dw, and DR antigens. All patients with SLE fulfilled at least four criteria of SLE and the patients with MCTD met the criteria proposed by Alarcon-Segovia (1989). The presence of antibodies to Sm was not considered as an exclusion for MCTD. In the patients with SLE, Dw3, DR3, and the associated B8 and A1 antigens were increased, whereas in the patients with MCTD an increased frequency of Dw4 was found (45 v 18% in controls v 14% in SLE). Of the subtypes of DR4, Dw4 was present in all but one of the DR4 positive patients. The frequency of DR4 in patients with MCTD (52%) differed significantly from that of controls (28%). The strong association of MCTD to one DR4 subtype was further seen in the significantly increased frequency of the B15, DR4 combination. Thus the genetic background seems to be different in patients with MCTD from that in patients with SLE. This could partly explain the clinical differences between these diseases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1540038      PMCID: PMC1004618          DOI: 10.1136/ard.51.1.52

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  24 in total

1.  HLA antigens Dw4 and Dw14 in rheumatoid arthritis.

Authors:  M Hakala; J Ilonen; A Tiilikainen
Journal:  Ann Rheum Dis       Date:  1987-06       Impact factor: 19.103

2.  Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA).

Authors:  G C Sharp; W S Irvin; E M Tan; R G Gould; H R Holman
Journal:  Am J Med       Date:  1972-02       Impact factor: 4.965

3.  HLA-Dw1 and BfF as protective markers in multiple sclerosis.

Authors:  J Ilonen; A Lagerstedt; S Koskimies; M Reunanen
Journal:  J Neuroimmunol       Date:  1983-12       Impact factor: 3.478

4.  Heterogeneity of systemic lupus erythematosus elucidated by cluster analysis. The influence of HLA.

Authors:  V Stenszky; L Kozma; G Szegedi; I Sonkoly; J C Bear; N R Farid
Journal:  J Immunogenet       Date:  1986-08

5.  HLA antigens associated with systemic lupus erythematosus in Japan.

Authors:  H Hashimoto; H Tsuda; T Matsumoto; H Nasu; Y Takasaki; Y Shokawa; S Hirose; P I Terasaki; Y Iwaki
Journal:  J Rheumatol       Date:  1985-10       Impact factor: 4.666

6.  HLA antigens and complotypes in insulin-dependent diabetes mellitus.

Authors:  J Partanen; S Koskimies; J Ilonen; M Knip
Journal:  Tissue Antigens       Date:  1986-05

7.  HLA-DR antigens in systemic lupus erythematosus: association with specificity of autoantibody responses to nuclear antigens.

Authors:  J S Smolen; J H Klippel; E Penner; M Reichlin; A D Steinberg; T M Chused; O Scherak; W Graninger; E Hartter; C C Zielinski
Journal:  Ann Rheum Dis       Date:  1987-06       Impact factor: 19.103

8.  [Significant association of HLA-B8 with systemic lupus erythematosus and with specific serological markers].

Authors:  C Specker; H J Lakomek; B M Kuntz; G Bremer; G Goerz; H L Krüskemper
Journal:  Dtsch Med Wochenschr       Date:  1987-04-10       Impact factor: 0.628

9.  HLA-DR4 and Gm(1,3;5,21) are associated with U1-nRNP antibody positive connective tissue disease.

Authors:  E Genth; H Zarnowski; R Mierau; D Wohltmann; P W Hartl
Journal:  Ann Rheum Dis       Date:  1987-03       Impact factor: 19.103

10.  Identification of HLA-Dw14 genes in DR4+ rheumatoid arthritis.

Authors:  G T Nepom; C E Seyfried; S L Holbeck; K R Wilske; B S Nepom
Journal:  Lancet       Date:  1986-11-01       Impact factor: 79.321

View more
  3 in total

Review 1.  Unraveling the genetics of systemic lupus erythematosus.

Authors:  John B Harley; Jennifer A Kelly; Kenneth M Kaufman
Journal:  Springer Semin Immunopathol       Date:  2006-09-22

Review 2.  "Mixed connective tissue disease": a condition in search of an identity.

Authors:  Marta R Alves; David A Isenberg
Journal:  Clin Exp Med       Date:  2020-03-04       Impact factor: 3.984

3.  Predisposition of HLA-DRB1*04:01/*15 heterozygous genotypes to Japanese mixed connective tissue disease.

Authors:  Shomi Oka; Takashi Higuchi; Hiroshi Furukawa; Kota Shimada; Atsushi Hashimoto; Akiko Komiya; Toshihiro Matsui; Naoshi Fukui; Eiichi Suematsu; Shigeru Ohno; Hajime Kono; Masao Katayama; Shouhei Nagaoka; Kiyoshi Migita; Shigeto Tohma
Journal:  Sci Rep       Date:  2022-06-15       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.